Selank in Polo — Anxiolytic Peptide Research Guide
Selank peptide guide for Polo. Covers anxiolytic mechanisms, purity standards, COA verification, nasal administration, and how to source quality Selank for research.
Unlike everyday supplements stocked in every health store, Selank reaches researchers through a specialist research supply market that Polo residents navigate through international suppliers. This matters because Selank quality ranges widely across the market — from verified research-grade material to products with serious contamination — and the vendor controls every quality variable. Separating quality Selank from the rest of the market comes down to three things: an HPLC chromatogram confirming ≥98% purity, mass spec data establishing the correct molecular weight, and a batch-specific endotoxin panel. This guide takes Polo researchers through that evaluation process and explains what quality documentation for Selank should look like.
What Studies Say About Selank
Selank belongs to a class of neuropeptides with documented activity in central nervous system models. Semax (ACTH4-7 Pro-Gly-Pro) is a synthetic analogue of adrenocorticotropic hormone fragments, and has been shown in animal and some human research to increase brain-derived neurotrophic factor (BDNF) expression — a key signal for neuroplasticity, neuronal survival, and synaptic strengthening. Selank, a synthetic analogue of the endogenous peptide tuftsin, has been shown to modulate GABAergic transmission and influence enkephalinase activity, producing anxiolytic and nootropic effects in rodent models. For researchers in Polo studying cognitive biology and neuropeptide pharmacology, these compounds represent a productive area where mechanistic specificity is well-characterized.
How to Evaluate Selank Vendors
The first step for any Polo researcher sourcing Selank is identifying 2-3 vendors with documented positive community reputations — commercial rankings reflect SEO budgets rather than product quality. When reviewing a Selank COA, verify: the batch number corresponds to your vial, HPLC purity is ≥98%, mass spec identifies the correct molecular weight, and endotoxin levels are at acceptable levels for the intended application. Positive vendor signals beyond COA quality: established track record of at least two years, customer service that can discuss analytical methods, and temperature-appropriate packaging with desiccant. The lyophilised (freeze-dried) form of Selank is always preferable to liquid pre-made solutions — lyophilised powder maintains stability for years when frozen, while liquid preparations degrade within weeks even when refrigerated.
Order Selank — ships to Polo
COA-verified · International tracking · Research grade
All use of Selank in Polo or anywhere must be research use only — this compound is not approved for therapeutic human application, and all handling should comply with standard research safety practices. Storage requirements for Selank: lyophilised powder at minus 20°C, reconstituted solution stored refrigerated at 2-8°C and used within 30 days; reconstitute only with sterile bacteriostatic water. Endotoxin testing in the Selank COA is absolutely required — gram-negative bacterial endotoxins can trigger dangerous immune responses at very low concentrations, and no cost saving makes omitting this acceptable. PubMed and related preprint servers represent the most comprehensive research databases for Selank research; prioritise peer-reviewed studies with characterised source material over case reports or anecdotal evidence.
Frequently Asked Questions
Is Selank similar to Semax?
Semax and Selank are both synthetic neuropeptides developed by the same Russian institution with overlapping clinical applications. They have distinct mechanisms: Semax primarily upregulates BDNF and acts on ACTH receptor systems; Selank primarily modulates GABAergic transmission and enkephalin activity. They are sometimes studied in combination.
What is Selank?
Selank is a synthetic analogue of tuftsin (a tetrapeptide fragment of immunoglobulin G) with three additional amino acids for stability. It has been studied for anxiolytic effects, cognitive enhancement, and GABAergic system modulation. Like Semax, it was developed by the Institute of Molecular Genetics in Russia and has a clinical history in Russian medicine.
How does Selank produce anxiolytic effects?
Selank's anxiolytic mechanism is thought to involve modulation of GABAergic transmission (similar but distinct to benzodiazepines), inhibition of enkephalinase (extending the activity of endogenous enkephalins), and BDNF expression modulation. The multi-mechanism profile distinguishes it from single-target anxiolytics.
What is the administration route for Selank research?
Like Semax, Selank is primarily studied via intranasal administration for CNS applications, utilizing olfactory nerve transport to bypass the blood-brain barrier. The solution concentration used in research is typically 0.15% (1.5mg/mL). Subcutaneous administration has also been studied in animal models.
